The Endometrial Ablation Market revenues were estimated at US$ 3.4 Bn in 2023 and are anticipated to grow at a CAGR of 7.3% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 6.8 Billion. The aggregate revenue from US and China was US$ 1.4 Billion in 2022.
With the advent of minimally invasive endometrial ablation treatments, the endometrium can be destroyed in a more expedient, outpatient setting. This operation is less dangerous and technically straightforward to carry out.
To learn more about this report @ https://www.futuremarketinsights.com/reports/endometrial-ablation-market
The International Federation of Gynaecology and Obstetrics estimates that between 3% and 30% of reproductive-aged women are affected by Abnormal Uterine Bleeding. Women's treatment plans have become the key focus of the general health industry in the modern world. Governments and private organizations around the world have placed women's health at the center of their wellbeing race.
In India, such as in many other locations, women are eligible for several tax benefits and exemptions under the provisions of several sections of the tax code. Women's healthcare initiatives may promote the effectiveness of treatment alternatives, which will boost the market.
Uterine Ablation is a medical procedure that involves the removal or destruction of the lining of the uterus, known as the endometrium. This procedure is often used to treat heavy or prolonged menstrual bleeding, and can be an alternative to a hysterectomy.
Competitive Landscape
• Medtronic
• CooperSurgical Inc.
• Boston Scientific Corp.
• Ethicon, Inc.
• Olympus Corp.
• Richard Wolf GmbH
• AngioDynamics
• Hologic, Inc.
• Minerva Surgical, Inc.
A few of the recent developments in the market are:
• In February 2021, CooperSurgical, a division of CooperCompanies, has acquired Aegea Medical, nearly a year after the company received FDA approval for its Mara water vapor ablation system for severe menstrual bleeding.
• In May 2019, Medtronic Plc announced a partnership with Koninklijke Philips N.V. This collaboration is projected to result in an integrated cryoablation solution that is cutting-edge in terms of image guidance.
• In April 2021, Olympus Corporation relocated its Therapeutic Solutions Division's worldwide headquarters from Tokyo to the United States in order to gain better access to the medical industry and earn more revenue through expanded commercial prospects.
• In June 2021, Boston Scientific purchased the remaining shares of FARAPULSE. Boston Scientific's electrophysiology sector was bolstered by the acquisition, which added pulsed-field ablation technology to the company's offerings.
Market Segments Covered in Endometrial Ablation Market Analysis
By Type:
• Devices
o Cryoablation
o Radiofrequency Ablation
o Hydrothermal Ablation
o Thermal Balloon
o Microwave Energy
• Procedures
By End User:
• Hospitals
• Clinics
• Ambulatory Surgery Centers